Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$1.94
+23.6%
$2.70
$1.40
$8.44
$3.16M1.89192,513 shs2.53 million shs
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$4.16
-0.7%
$4.70
$3.42
$25.50
$2.28M0.75237,129 shs209,614 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.08
+9.3%
$0.09
$0.06
$0.34
$812K0.517,766 shs12,014 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.20
+0.9%
$2.42
$2.10
$14.50
$3.11M0.07607,188 shs33,125 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
+23.57%+11.49%-36.10%-33.87%-58.55%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-0.72%-20.76%-17.46%-15.45%-40.74%
Dynatronics Co. stock logo
DYNT
Dynatronics
+9.29%-13.17%-5.67%-30.45%-77.36%
Venus Concept Inc. stock logo
VERO
Venus Concept
+0.92%-8.71%-4.35%-20.00%-75.57%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
3.1288 of 5 stars
3.55.00.00.02.40.01.3
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
1.8899 of 5 stars
0.05.00.00.03.80.01.3
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
2.9944 of 5 stars
0.05.00.00.04.43.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
3.00
Buy$56.002,786.60% Upside
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
0.00
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$570K6.84N/AN/A$17.54 per share0.11
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/A$8.39 per shareN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.02N/AN/A$0.57 per share0.13
Venus Concept Inc. stock logo
VERO
Venus Concept
$64.83M0.05N/AN/A$4.30 per share0.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$12.21M-$12.64N/AN/AN/AN/A-153.96%-109.13%8/12/2025 (Estimated)
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$4.11MN/A0.00N/AN/AN/A-130.21%-119.39%8/8/2025 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.78N/AN/A-8.35%-41.81%-9.56%N/A
Venus Concept Inc. stock logo
VERO
Venus Concept
-$47M-$76.30N/AN/A-81.26%-752.29%-54.52%8/12/2025 (Estimated)

Latest DYNT, BBLG, AEMD, and VERO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million
5/12/2025Q1 2025
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$2.88-$1.92+$0.96-$0.32N/AN/A
3/31/2025Q4 2024
Venus Concept Inc. stock logo
VERO
Venus Concept
-$10.0089-$11.23-$1.2211-$11.23$16.99 million$15.77 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/AN/A
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/A
2.80
2.80
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/A
12.60
12.60
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
Venus Concept Inc. stock logo
VERO
Venus Concept
7.91
1.28
0.79

Institutional Ownership

CompanyInstitutional Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.99%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
34.30%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%

Insider Ownership

CompanyInsider Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.20%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
6.10%
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
102.01 million1.99 millionNo Data
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
2550,000512,000Not Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20010.62 million8.11 millionNot Optionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million1.03 millionNot Optionable

Recent News About These Companies

Venus Concept Inc News (VERO) - Investing.com
Venus Concept Shares Soar on Sale of Hair Business

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aethlon Medical stock logo

Aethlon Medical NASDAQ:AEMD

$1.94 +0.37 (+23.57%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$1.44 -0.51 (-26.03%)
As of 05:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLG

$4.16 -0.03 (-0.72%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$3.92 -0.24 (-5.65%)
As of 04:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.08 +0.01 (+9.29%)
As of 06/26/2025 03:48 PM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.20 +0.02 (+0.92%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$2.27 +0.07 (+3.14%)
As of 04:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.